Skip to main content
Erschienen in: Die Radiologie 12/2009

01.12.2009 | Leitthema

Bildgebende Verfahren bei gastrointestinalen Stromatumoren

verfasst von: Prof. Dr. G. Antoch, K. Herrmann, T.A. Heusner, A.K. Buck

Erschienen in: Die Radiologie | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Zusammenfassung

Morphologische und funktionelle bildgebende Verfahren werden für das Staging gastrointestinaler Stromatumoren (GIST) sowie die Verlaufskontrolle von GIST unter Therapie eingesetzt. Die Computertomographie (CT) wird am häufigsten in der klinischen Routine verwendet und wird von internationalen Richtlinien als Standardverfahren empfohlen. Die Positronenemissionstomographie mit [18F]-2‚-Fluoro-2‚-desoxy-D-Glukose (FDG-PET) kann insbesondere bei der Beurteilung des Ansprechens eines GIST auf die Therapie den rein morphologischen bildgebenden Verfahren überlegen sein. Während die Größe eines Tumorherdes unter Therapie nur sehr langsam abnimmt, kann die FDG-PET ein Ansprechen des Tumors bereits 24 h nach der Therapieeinleitung nachweisen. Aber auch mit der CT ermöglichen neue, dichtebasierte Kriterien deutlich früher den Nachweis eines Therapieansprechens im Vergleich zu einer rein größenbasierten Auswertung. Diese Übersichtsarbeit behandelt die Indikationen bildgebender Verfahren bei GIST und gibt einen Überblick charakteristischer bildgebender Befunde beim Staging und der Therapiekontrolle.
Literatur
1.
Zurück zum Zitat Antoch G, Kanja J, Bauer S et al (2004) Comparison of PET, CT and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med 45:357–365PubMed Antoch G, Kanja J, Bauer S et al (2004) Comparison of PET, CT and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med 45:357–365PubMed
2.
Zurück zum Zitat Bauer S, Hartmann JT, de Wit M et al (2005) Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib. Int J Cancer 117:316–325CrossRefPubMed Bauer S, Hartmann JT, de Wit M et al (2005) Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib. Int J Cancer 117:316–325CrossRefPubMed
3.
Zurück zum Zitat Blay JY, Bonvalot S, Casali P et al (2005) Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 16:566–578CrossRefPubMed Blay JY, Bonvalot S, Casali P et al (2005) Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 16:566–578CrossRefPubMed
4.
Zurück zum Zitat Burkill GJ, Badran M, Al-Muderis O et al (2003) Malignant gastrointestinal stromal tumor: distribution, imaging features and pattern of metastatic spread. Radiology 226:527–532CrossRefPubMed Burkill GJ, Badran M, Al-Muderis O et al (2003) Malignant gastrointestinal stromal tumor: distribution, imaging features and pattern of metastatic spread. Radiology 226:527–532CrossRefPubMed
5.
Zurück zum Zitat Chen MYM, Bechtold RE, Savage PD (2002) Cystic changes in hepatic metastases from gastrointestinal strom tumors. AJR Am J Roentgenol 179:1059–1062PubMed Chen MYM, Bechtold RE, Savage PD (2002) Cystic changes in hepatic metastases from gastrointestinal strom tumors. AJR Am J Roentgenol 179:1059–1062PubMed
6.
Zurück zum Zitat Choi H (2005) Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model. Curr Oncol Rep 7:307–311CrossRefPubMed Choi H (2005) Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model. Curr Oncol Rep 7:307–311CrossRefPubMed
7.
Zurück zum Zitat Choi H, Charnsangavej C, Faria SC et al (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25:1753–1759CrossRefPubMed Choi H, Charnsangavej C, Faria SC et al (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25:1753–1759CrossRefPubMed
8.
Zurück zum Zitat Choi H, Faria SC, Podoloff DA et al (2002) Monitoring treatment effects of STI-571 on gastrointestinal stromal tumors (GIST) with CT and PET: a quantitative analysis. Radiology 225:583CrossRef Choi H, Faria SC, Podoloff DA et al (2002) Monitoring treatment effects of STI-571 on gastrointestinal stromal tumors (GIST) with CT and PET: a quantitative analysis. Radiology 225:583CrossRef
9.
Zurück zum Zitat Demetri GD, Benjamin RS, Blanke CD et al (2007) NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5 [suppl 2]:S1–S29; quiz S30 Demetri GD, Benjamin RS, Blanke CD et al (2007) NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5 [suppl 2]:S1–S29; quiz S30
10.
Zurück zum Zitat Fletcher CD, Berman JJ, Corless C et al (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459–465CrossRefPubMed Fletcher CD, Berman JJ, Corless C et al (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459–465CrossRefPubMed
11.
Zurück zum Zitat Gayed I, Vu T, Iyer R et al (2004) The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med 45:17–21PubMed Gayed I, Vu T, Iyer R et al (2004) The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med 45:17–21PubMed
12.
Zurück zum Zitat Ghanem N, Altehoefer C, Hogerle S et al (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial skeleton. Eur J Radiol 43:256–261CrossRefPubMed Ghanem N, Altehoefer C, Hogerle S et al (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial skeleton. Eur J Radiol 43:256–261CrossRefPubMed
13.
Zurück zum Zitat Goerres GW, Stupp R, Barghouth G et al (2005) The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 32:153–162CrossRefPubMed Goerres GW, Stupp R, Barghouth G et al (2005) The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 32:153–162CrossRefPubMed
14.
Zurück zum Zitat Hersh MR, Choi J, Garrett C, Clark R (2005) Imaging gastrointestinal stromal tumors. Cancer Control 12:111–115PubMed Hersh MR, Choi J, Garrett C, Clark R (2005) Imaging gastrointestinal stromal tumors. Cancer Control 12:111–115PubMed
15.
Zurück zum Zitat Holdsworth CH, Badawi RD, Manola JB et al (2007) CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor. AJR 189:W324–330CrossRefPubMed Holdsworth CH, Badawi RD, Manola JB et al (2007) CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor. AJR 189:W324–330CrossRefPubMed
16.
Zurück zum Zitat Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis and differential diagnosis. Arch Pathol Lab Med 130:1466–1478PubMed Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis and differential diagnosis. Arch Pathol Lab Med 130:1466–1478PubMed
17.
Zurück zum Zitat Prior JO, Montemurro M, Orcurto MV et al (2009) Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor. J Clin Oncol 27:439–445CrossRefPubMed Prior JO, Montemurro M, Orcurto MV et al (2009) Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor. J Clin Oncol 27:439–445CrossRefPubMed
18.
Zurück zum Zitat Sandrasegaran K, Rajesh A, Rushing DA et al (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15:1407–1414CrossRefPubMed Sandrasegaran K, Rajesh A, Rushing DA et al (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15:1407–1414CrossRefPubMed
19.
Zurück zum Zitat Shankar S, van Sonnenberg E, Desai J et al (2005) Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate. Radiology 235:892–898CrossRefPubMed Shankar S, van Sonnenberg E, Desai J et al (2005) Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate. Radiology 235:892–898CrossRefPubMed
20.
Zurück zum Zitat Stroobants S, Goeminne J, Seegers M et al (2003) 18FDG-positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (glivec). Eur J Cancer 39:2012–2020CrossRefPubMed Stroobants S, Goeminne J, Seegers M et al (2003) 18FDG-positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (glivec). Eur J Cancer 39:2012–2020CrossRefPubMed
21.
Zurück zum Zitat Tateishi U, Hasegawa T, Satake M, Moriyama N (2003) Gastrointestinal stromal tumor. Correlation of computed tomography findings with tumor grade and mortality. J Comput Assist Tomogr 27:792–798CrossRefPubMed Tateishi U, Hasegawa T, Satake M, Moriyama N (2003) Gastrointestinal stromal tumor. Correlation of computed tomography findings with tumor grade and mortality. J Comput Assist Tomogr 27:792–798CrossRefPubMed
22.
Zurück zum Zitat Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216CrossRefPubMed Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216CrossRefPubMed
23.
Zurück zum Zitat Van den Abbeele AD (2008) The lessons of GIST-PET and PET/CT: a new paradigm for imaging. Oncologist 13 [suppl 2]:8–13 Van den Abbeele AD (2008) The lessons of GIST-PET and PET/CT: a new paradigm for imaging. Oncologist 13 [suppl 2]:8–13
24.
Zurück zum Zitat WHO (1979) WHO handbook of reporting results of cancer treatment. World Health Organization Offset Publication No. 48, Geneva WHO (1979) WHO handbook of reporting results of cancer treatment. World Health Organization Offset Publication No. 48, Geneva
25.
Zurück zum Zitat Young H, Baum R, Cremerius U et al (1999) Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35:1773–1782CrossRefPubMed Young H, Baum R, Cremerius U et al (1999) Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35:1773–1782CrossRefPubMed
Metadaten
Titel
Bildgebende Verfahren bei gastrointestinalen Stromatumoren
verfasst von
Prof. Dr. G. Antoch
K. Herrmann
T.A. Heusner
A.K. Buck
Publikationsdatum
01.12.2009
Verlag
Springer-Verlag
Erschienen in
Die Radiologie / Ausgabe 12/2009
Print ISSN: 2731-7048
Elektronische ISSN: 2731-7056
DOI
https://doi.org/10.1007/s00117-009-1852-9

Weitere Artikel der Ausgabe 12/2009

Die Radiologie 12/2009 Zur Ausgabe

CME Weiterbildung • Zertifizierte Fortbildung

Das Who Is Who der Extremitätenfrakturen

Berufsverband der Deutschen Radiologen (BDR) - Mitteilungen

Mitteilungen des BDR

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.